NCT04946812

Brief Summary

Parkinson's disease (PD) related gait and balance disorders are challenging to treat because they cannot be optimized with pharmacological intervention alone. This treatment gap is important to address because gait asymmetry and incoordination are associated with increased falls in this population, which can be functionally debilitating and lead to increased morbidity and mortality. Freezing of gait (FOG) has also been associated with reduced quality of life independent of its association with impaired mobility. Gait disorders therefore represent an unmet need in the treatment of PD. A split-belt treadmill (SB-TM) can be used to adjust the speed of each leg separately and individuals can be prompted to 'adapt' to an asymmetric gait and 're-adapt' with return to symmetrical gait in a phenomenon known as 'after-effect'.

Trial Health

55
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
28

participants targeted

Target at P25-P50 for not_applicable parkinson-disease

Timeline
Completed

Started Mar 2020

Longer than P75 for not_applicable parkinson-disease

Geographic Reach
1 country

1 active site

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 27, 2020

Completed
1.2 years until next milestone

First Submitted

Initial submission to the registry

June 12, 2021

Completed
19 days until next milestone

First Posted

Study publicly available on registry

July 1, 2021

Completed
3.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2024

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2025

Completed
Last Updated

July 17, 2024

Status Verified

July 1, 2024

Enrollment Period

4.7 years

First QC Date

June 12, 2021

Last Update Submit

July 16, 2024

Conditions

Outcome Measures

Primary Outcomes (1)

  • Falls

    The incidence of falls for 3 months after completing treadmill training. Falls will also be assessed at multiple stages during the 7.5-month study period, to understand the duration of benefit of this intervention. This data will be obtained from the falls calendar that will be provided to subjects upon their recruitment to the study.

    3 months after completion of treadmill training

Secondary Outcomes (17)

  • Gait parameters between intervention and control groups

    Obtained at baseline evaluation, after 1.5 months of training, and 3-months post intervention

  • Gait parameters between intervention and control groups

    Obtained at baseline evaluation, after 1.5 months of training, and 3-months post intervention

  • Gait parameters between intervention and control groups

    Obtained at baseline evaluation, after 1.5 months of training, and 3-months post intervention

  • Gait parameters between intervention and control groups

    Obtained at baseline evaluation, after 1.5 months of training, and 3-months post intervention

  • Gait parameters between intervention and control groups

    Obtained at baseline evaluation, after 1.5 months of training, and 3-months post intervention

  • +12 more secondary outcomes

Study Arms (2)

Intervention group

EXPERIMENTAL

The velocity of the belt will be adjusted to the over-ground speed of the subject, and will be reduced on the least affected side by 25%. While the speed of the treadmill will not change throughout the study, the duration of the training will increase each week. In the first week, the SBTM training will take place for 10 minutes. There will be a 5-minute rest period, and the split-belt conditions will continue for another 10 minutes of training (total training time= 20 minutes).

Other: Split-belt treadmill training

Control group

ACTIVE COMPARATOR

The subject will continue to walk under tied-belt conditions adjusted to the over-ground walking speed. In the first week, the treadmill training will be for 10 minutes. They will get a 5-minute break, similar to the intervention group, and continue for another 10 minutes under tied-belt conditions. The duration of each session will increase by 8 minutes every week. For example, in week 1, the treadmill training will be for a total of 20 minutes; in week 2, for 28 minutes; in week 3, for 36 minutes, and so forth, until it gets to 60 minutes by week 6. The rest period will remain at 5 minutes each session, and will always take place at the halfway mark. All 3 sessions in the week will have the same duration of training. If the subject cannot tolerate the velocity or duration of the session, the protocol will be adjusted to most recently tolerated session (and will be recorded for further interpretation and analysis).

Other: Split-belt treadmill training

Interventions

18 sessions of SB-TM training, where the velocity of the belt will be adjusted to the over-ground speed of the subject, and will be reduced on the least affected side by 25%.

Control groupIntervention group

Eligibility Criteria

Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • Idiopathic PD
  • Hoehn \& Yahr Stage 2-3, on levodopa
  • FOG, resistant to dopaminergic therapy
  • Disease duration: 5-15 years
  • Stable clinical response to medications or stimulation parameters (in case of DBS) for at least 3 months
  • MMSE \>24/30
  • Able to walk on a motor-driven treadmill

You may not qualify if:

  • Severe imbalance that limits ambulation (Hoehn \&Yahr score above 3)
  • Orthopedic conditions and other systemic disease affecting locomotion
  • Cardiac conditions limiting the ability to walk uninterrupted for 1 hour
  • Presence of other neurological disorder
  • Inability to be fluent in English

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Toronto Western Hospital

Toronto, Ontario, M5T 2S8, Canada

Location

MeSH Terms

Conditions

Parkinson DiseaseGait Disorders, Neurologic

Condition Hierarchy (Ancestors)

Parkinsonian DisordersBasal Ganglia DiseasesBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesMovement DisordersSynucleinopathiesNeurodegenerative DiseasesNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Masking Details
This is a prospective, single-blind, parallel-group randomized control trial to assess the feasibility and safety of SBTM in preventing falls and improving gait and balance, as well as its efficacy compared to TM training. The assessor will be blinded to their randomization. Patients will not be blinded to the intervention, and will be informed about the rationale of the study.
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Split-belt treadmill (Grail systems®, by Motek, Netherlands)
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Clinician Investigator, Staff Neurologist

Study Record Dates

First Submitted

June 12, 2021

First Posted

July 1, 2021

Study Start

March 27, 2020

Primary Completion

December 1, 2024

Study Completion

March 1, 2025

Last Updated

July 17, 2024

Record last verified: 2024-07

Locations